Abstract
A total of 169 individuals participated in the study. 89 cases constituted the post-COVID group and 80 cases constituted the control group. In our case series, patients were in the post-COVID period and the control groups were assessed with the Douleur Neuropathique 4 (DN4) and Self-Leeds Assessment of Neuropathic Symptoms and Sign (SLANSS) questionnaire for neuropathic pain.
Cite
CITATION STYLE
APA
Sinan, E., Funda UYSAL, T., & Aysel KOCAGÜL, Ç. (2022). Post-COVID 19 and Neuropathic Pain. Journal of Infectious Diseases and Epidemiology, 8(2). https://doi.org/10.23937/2474-3658/1510247
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free